COMPANY
NANJING CELLNUO BIOPHARMACEUTICAL CO LTD
NANJING CELLNUO BIOPHARMACEUTICAL CO LTD: API manufacturer for Retatrutide, Semaglutide, Tirzepatide, as stated by public registers.
API MANUFACTURER
Filed a drug master file with FDA for the active ingredient.
| Retatrutide | DMF 42856, type II, active, submitted 2025-10-24 Regulator FDA drug master file list |
|---|---|
| Semaglutide | DMF 39847, type II, active, submitted 2024-06-15 Regulator FDA drug master file list |
| Tirzepatide | DMF 41650, type II, active, submitted 2025-03-28 Regulator FDA drug master file list |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.